<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="27899">Cisplatin</z:chebi> is commonly used against several <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> is an effective cytotoxic drug used in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A major clinical issue affecting 10-40 % of patients treated with <z:chebi fb="2" ids="27899">cisplatin</z:chebi> or <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> is severe <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> causing sensory, motor, and <z:hpo ids='HP_0002459'>autonomic dysfunction</z:hpo>, with symptoms including cold sensitivity and neuropathic pain </plain></SENT>
<SENT sid="2" pm="."><plain>The biochemical basis of the neurotoxicity is uncertain, but is associated with <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> (a natural phenolic yellow pigment) has strong <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, anticancer, and anti-inflammatory actions </plain></SENT>
<SENT sid="4" pm="."><plain>Here we report the possible protective effect of <z:chebi fb="0" ids="3962">curcumin</z:chebi> on some <z:chebi fb="2" ids="27899">cisplatin</z:chebi>- and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-induced behavioral, biochemical, and histopathological alterations in rats </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four hours after the end of treatments some motor and behavioral tests (motor activity, thermal and mechanical nociception, and neuromuscular coordination) were conducted, followed by measuring plasma <z:chebi fb="0" ids="7542">neurotensin</z:chebi> <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> concentration in the sciatic nerve, and studying the histopathology of the sciatic nerve </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> (4 mg/kg) and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> (2 mg/kg) [each given twice weekly, in a total of nine intraperitoneal injections over 4.5 weeks] significantly increased plasma <z:chebi fb="0" ids="7542">neurotensin</z:chebi> concentration, caused specific damage in the histology of the sciatic nerve and produced variable effects in the motor and behavioral tests </plain></SENT>
<SENT sid="7" pm="."><plain>Oral <z:chebi fb="0" ids="3962">curcumin</z:chebi> (10 mg/kg, 4 days before the <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> drug, and thereafter, concomitantly with it for 4.5 weeks) reversed the alterations in the plasma <z:chebi fb="0" ids="7542">neurotensin</z:chebi> and sciatic nerve <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> concentrations, and markedly improved sciatic nerve histology in the <z:chebi fb="240" ids="33364,33400">platinum</z:chebi>-treated rats </plain></SENT>
<SENT sid="8" pm="."><plain>Larger experiments using a wider dose range of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, <z:chebi fb="2" ids="27899">cisplatin</z:chebi>, and <z:chebi fb="0" ids="3962">curcumin</z:chebi> are required to fully elucidate the possible protective role of <z:chebi fb="0" ids="3962">curcumin</z:chebi> in <z:chebi fb="240" ids="33364,33400">platinum</z:chebi>-induced neurotoxicity </plain></SENT>
</text></document>